Blocking the B7RP1/ICOS-L pathway has been shown to decrease the differentiation of CD4+ naïve T cells into TFH cells and inhibit germinal center formation55 and thus could decrease B cell activation and ectopic lymphoid tissue formation in the target organs of primary Sjögren’s syndrome. The gene discussed is ICOSLG; the disease is Sjogren syndrome.